Treatment of advanced mesothelioma with the recombinant adenovirus H5.010RSVTK: a phase 1 trial (BB-IND 6274).
Treat
J
J
Kaiser
L R
LR
Sterman
D H
DH
Litzky
L
L
Davis
A
A
Wilson
J M
JM
Albelda
S M
SM
D000260:Adenoviruses, Human / Q000235:genetics*; D000998:Antiviral Agents / Q000494:pharmacology*; D002985:Clinical Protocols; D015774:Ganciclovir / Q000494:pharmacology*; D005822:Genetic Vectors; D018259:Herpesvirus 1, Human / Q000201:enzymology*; D006801:Humans; D008654:Mesothelioma / Q000628:therapy*; D011995:Recombination, Genetic; D013937:Thymidine Kinase / Q000235:genetics / Q000627:therapeutic use*
D000998:Antiviral Agents; D013937:Thymidine Kinase; D015774:Ganciclovir